A north central cancer treatment group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

✍ Scribed by Henry C. Pitot; James A. Knost; Michelle R. Mahoney; John Kugler; James E. Krook; Alan K. Hatfield; Daniel J. Sargent; Richard M. Goldberg

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 94 KB
• Volume: 89
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(20001015)89:8<1699::aid-cncr8>3.0.co;2-t